跳至主要内容
临床试验/NCT02035293
NCT02035293已完成不适用

Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

University Hospital, Brest13 个研究点 分布在 1 个国家目标入组 750 人开始时间: 2014年1月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
750
试验地点
13
主要终点
Frequency of pulmonary embolism in patients hospitalized for a clinical exacerbation of COPD.

研究概览

简要总结

A standardized diagnostic strategy of pulmonary embolism will be applied to eligible patients, incorporating a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a multidetector-row CT angiography thoracic and venous ultrasound of the lower limbs. All the patient with a pulmonary embolism diagnosed or not, will be followed for 3 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients hospitalized for a COPD exacerbation
  • COPD previously diagnosed

排除标准

  • Allergy to iodinated contrast
  • Creatinine clearance < 30 mL / min
  • Patient hospitalized for exacerbation of COPD for more than 48 hours
  • Pneumothorax
  • Exams impossible to be performed
  • Pregnancy
  • Life expectancy < 3 months
  • Patients already receiving anticoagulant therapy for another reason (mechanical valve, cardiac arrhythmia).

研究组 & 干预措施

PEP

Other

No drug and no placebo were used in this study. For all the patients who participated at the study PEP, only following exams must be performed: a clinical probability score (revised Geneva score), plasma D-dimer assay and if necessary, a chest multidetector-row CT angiography and venous ultrasound of the lower limbs

干预措施: PEP (Other)

结局指标

主要结局

Frequency of pulmonary embolism in patients hospitalized for a clinical exacerbation of COPD.

时间窗: 27 months

次要结局

  • The rate of pulmonary embolism diagnosed during the 3 month follow-up in patients whom pulmonary embolism was initially excluded when they've been included in the study(27 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验